Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study

Objectives: Gout is the most common form of inflammatory arthritis and was found to be independently associated with incident dementia in the elderly. However, the associations between anti-gout preparations and dementia were not well-studied.Methods: Data were collected from Taiwan's National...

Full description

Bibliographic Details
Main Authors: Tsung-Ju Chuang, Yu-Hsun Wang, James Cheng-Chung Wei, Chih-Jung Yeh
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.607808/full
_version_ 1818595394829942784
author Tsung-Ju Chuang
Tsung-Ju Chuang
Yu-Hsun Wang
James Cheng-Chung Wei
James Cheng-Chung Wei
James Cheng-Chung Wei
Chih-Jung Yeh
author_facet Tsung-Ju Chuang
Tsung-Ju Chuang
Yu-Hsun Wang
James Cheng-Chung Wei
James Cheng-Chung Wei
James Cheng-Chung Wei
Chih-Jung Yeh
author_sort Tsung-Ju Chuang
collection DOAJ
description Objectives: Gout is the most common form of inflammatory arthritis and was found to be independently associated with incident dementia in the elderly. However, the associations between anti-gout preparations and dementia were not well-studied.Methods: Data were collected from Taiwan's National Health Insurance Research Database (NHIRD). A 2005–2013 retrospective cohort study was conducted, and all investigated subjects were identified by International Statistical Classification of Diseases and Related Health Problems, 9th Revision, Clinical Modification. Conditional logistic regression was used to evaluate the odds ratio of dementia in relation to different gout preparations (benzbromarone, allopurinol, sulfinpyrazone, probenecid) and number of days of anti-gout preparation use, after adjustment for potential confounding variables.Results: A total of 3,242 gout patients with and without dementia were selected from the NHIRD and included in the final analysis after 1:1 matching for age, gender, and diagnosis year of gout. In the anti-gout preparations, only use of Benzbromarone decreased the risk of dementia (adjusted OR, 0.81; 95% CI, 0.68–0.97). The result of the subgroup analysis revealed a trend toward a lower risk of dementia with longer use of benzbromarone. Use of benzbromarone for ≥180 days showed a significantly lower risk of dementia (adjusted OR, 0.72; 95% CI, 0.58–0.89). Moreover, the protective effect was more pronounced in males compared with females.Conclusion: This cohort study reveals that gout patients taking benzbromarone are at a decreased risk of developing incident dementia, especially with longer use and in male. Further prospective trials are warranted to confirm our findings.
first_indexed 2024-12-16T11:15:19Z
format Article
id doaj.art-99a9e7d9ad9947e2b82b1cae958b2ac6
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-16T11:15:19Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-99a9e7d9ad9947e2b82b1cae958b2ac62022-12-21T22:33:37ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-01-01710.3389/fmed.2020.607808607808Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort StudyTsung-Ju Chuang0Tsung-Ju Chuang1Yu-Hsun Wang2James Cheng-Chung Wei3James Cheng-Chung Wei4James Cheng-Chung Wei5Chih-Jung Yeh6Division of Endocrinology and Metabolism, Department of Internal Medicine, National Defense Medical Center, Taichung Armed Forces General Hospital, Taichung, TaiwanSchool of Public Health, Chung Shan Medical University, Taichung, TaiwanDepartment of Medical Research, Chung Shan Medical University Hospital, Taichung, TaiwanDepartment of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, TaiwanInstitute of Medicine, College of Medicine, Chung Shan Medical University, Taichung, TaiwanGraduate Institute of Integrated Medicine, China Medical University, Taichung, TaiwanSchool of Public Health, Chung Shan Medical University, Taichung, TaiwanObjectives: Gout is the most common form of inflammatory arthritis and was found to be independently associated with incident dementia in the elderly. However, the associations between anti-gout preparations and dementia were not well-studied.Methods: Data were collected from Taiwan's National Health Insurance Research Database (NHIRD). A 2005–2013 retrospective cohort study was conducted, and all investigated subjects were identified by International Statistical Classification of Diseases and Related Health Problems, 9th Revision, Clinical Modification. Conditional logistic regression was used to evaluate the odds ratio of dementia in relation to different gout preparations (benzbromarone, allopurinol, sulfinpyrazone, probenecid) and number of days of anti-gout preparation use, after adjustment for potential confounding variables.Results: A total of 3,242 gout patients with and without dementia were selected from the NHIRD and included in the final analysis after 1:1 matching for age, gender, and diagnosis year of gout. In the anti-gout preparations, only use of Benzbromarone decreased the risk of dementia (adjusted OR, 0.81; 95% CI, 0.68–0.97). The result of the subgroup analysis revealed a trend toward a lower risk of dementia with longer use of benzbromarone. Use of benzbromarone for ≥180 days showed a significantly lower risk of dementia (adjusted OR, 0.72; 95% CI, 0.58–0.89). Moreover, the protective effect was more pronounced in males compared with females.Conclusion: This cohort study reveals that gout patients taking benzbromarone are at a decreased risk of developing incident dementia, especially with longer use and in male. Further prospective trials are warranted to confirm our findings.https://www.frontiersin.org/articles/10.3389/fmed.2020.607808/fullgouturic aciddementiabenzbromaroneelderly
spellingShingle Tsung-Ju Chuang
Tsung-Ju Chuang
Yu-Hsun Wang
James Cheng-Chung Wei
James Cheng-Chung Wei
James Cheng-Chung Wei
Chih-Jung Yeh
Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
Frontiers in Medicine
gout
uric acid
dementia
benzbromarone
elderly
title Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
title_full Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
title_fullStr Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
title_full_unstemmed Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
title_short Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
title_sort association between use of anti gout preparations and dementia nested case control nationwide population based cohort study
topic gout
uric acid
dementia
benzbromarone
elderly
url https://www.frontiersin.org/articles/10.3389/fmed.2020.607808/full
work_keys_str_mv AT tsungjuchuang associationbetweenuseofantigoutpreparationsanddementianestedcasecontrolnationwidepopulationbasedcohortstudy
AT tsungjuchuang associationbetweenuseofantigoutpreparationsanddementianestedcasecontrolnationwidepopulationbasedcohortstudy
AT yuhsunwang associationbetweenuseofantigoutpreparationsanddementianestedcasecontrolnationwidepopulationbasedcohortstudy
AT jameschengchungwei associationbetweenuseofantigoutpreparationsanddementianestedcasecontrolnationwidepopulationbasedcohortstudy
AT jameschengchungwei associationbetweenuseofantigoutpreparationsanddementianestedcasecontrolnationwidepopulationbasedcohortstudy
AT jameschengchungwei associationbetweenuseofantigoutpreparationsanddementianestedcasecontrolnationwidepopulationbasedcohortstudy
AT chihjungyeh associationbetweenuseofantigoutpreparationsanddementianestedcasecontrolnationwidepopulationbasedcohortstudy